IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dong, Y.
Right arrow Articles by Bushkin, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dong, Y.
Right arrow Articles by Bushkin, Y.

 Previous Article  |  Next Article 

Infection and Immunity, April 2004, p. 2412-2415, Vol. 72, No. 4
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.4.2412-2415.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

HLA-A2-Restricted CD8+-Cytotoxic-T-Cell Responses to Novel Epitopes in Mycobacterium tuberculosis Superoxide Dismutase, Alanine Dehydrogenase, and Glutamine Synthetase

Yuzhi Dong,1 Sandra Demaria,2 Xuming Sun,1 Fabio R. Santori,2 Bill M. Jesdale,3 Anne S. De Groot,3 William N. Rom,2 and Yuri Bushkin1*

Laboratory of Molecular Immunology, Public Health Research Institute, Newark, New Jersey 07103,1 New York University School of Medicine, New York, New York 10016,2 Brown University School of Medicine, Providence, Rhode Island 029123

Received 21 July 2003/ Returned for modification 20 October 2003/ Accepted 16 January 2004


   ABSTRACT
Top
 Abstract
Text
 References
 
Major histocompatibility complex class I-restricted CD8+ cytotoxic T lymphocytes (CTL) are implicated in protective Th1 immunity to Mycobacterium tuberculosis infection. We report the identification of three novel HLA-A*0201-restricted CTL epitopes within mycobacterial superoxide dismutase (SodA), L-alanine dehydrogenase (AlaDH), and L-glutamine synthetase (GlnS) proteins.


   TEXT
Top
 Abstract
 Text
References
 
Cellular immunity is essential for protection against infections caused by intracellular pathogens, including Mycobacterium tuberculosis (20). Major histocompatibility complex (MHC) class I-restricted CD8+ cytotoxic T lymphocytes (CTL) contribute to the control of M. tuberculosis infection by mediating specific effector functions, including lysis of infected cells, direct antimicrobial activity, and release of Th1 cytokines that activate antimycobacterial mechanisms in macrophages (7, 19, 23). Still, only a small number of MHC class I-restricted CTL epitopes have been identified within a few mycobacterial proteins. The human CD8+ CTL specific for immunodominant epitopes derived from M. tuberculosis proteins lyse infected cells and readily release gamma interferon (IFN-{gamma}) upon recognition of their targets (3, 4, 8, 11, 12, 15, 17, 21). Several mycobacterial enzymes including SodA, AlaDH, and GlnS were previously identified in culture fluids of in vitro-growing bacilli (1, 2, 22). These enzymes may have important functions in pathogenicity of mycobacteria. Their extracellular expression reflects intracellular abundance and stability and may result from bacterial autolysis (26). Whether mycobacterial superoxide dismutase (SodA), L-alanine dehydrogenase (AlaDH), and L-glutamine synthetase (GlnS) can induce human CD8+-CTL responses has not been previously investigated.

First, the relative affinities and stabilization capacities of synthetic peptides selected from the M. tuberculosis proteins SodA, AlaDH, and GlnS for the presence of HLA-A*0201 allele-binding motifs were measured in stabilization assays with T2 cells (16, 24) (Table 1). Binding of exogenous peptides to surface HLA-A2 molecules increased levels of expression of peptide-ligand complexes in T2 cells, as detected by immunostaining with conformation-specific monoclonal antibody (MAb) MA2.1 and flow cytometry, and allowed for selection of potential CTL epitopes. Next, memory CTL responses against peptide-pulsed T2 target cells were measured in peripheral blood mononuclear cells (PBMC) obtained from HLA-A*0201-positive tuberculosis (TB) patients (n = 8) and healthy individuals with positive tuberculin skin tests (TST+ individuals; n = 8) or negative tuberculin skin tests (TST- individuals; n = 2). The protocol and consent forms describing the involvement of human subjects were approved by the New York University School of Medicine Institutional Review Board for the Bellevue Hospital. Whole PBMC were stimulated with each peptide for 10 to 14 days in the presence of interleukin-2 and interleukin-7 (4, 12, 21). Responding CTL were amplified by restimulation rounds with HLA-A*0201-expressing JY lymphoblastoid cells pulsed with peptides and allogeneic PBMC as feeder cells. Overall, there was no correlation between relative affinities of peptides for HLA-A*0201 and their abilities to amplify specific CTL responses (Table 1). In contrast, the stability of peptide-ligand complexes on the cell surface appears to be important because complexes with half-lives of less than 6 h were not recognized by CTL. CTL specific for the peptide comprising amino acids 160 to 168 of SodA (SodA160-168) were found in three of eight TB patients and in two of eight TST+ individuals, while AlaDH160-169- and GlnS308-316-specific CTL were absent in TB patients but present in two of eight and three of four TST+ individuals, respectively. No CTL responses specific for these epitopes were detected in TST- individuals.


View this table:
[in this window]
[in a new window]
  		TABLE 1. CTL epitopes identified within HLA-A*0201-binding peptides derived from mycobacterial SodA, AlaDH, and GlnS proteins

 
CTL assays demonstrated that the SodA160-168, AlaDH160-169, and GlnS308-316 peptides are novel CTL epitopes as peptide-pulsed T2 cells were specifically and efficiently lysed by effectors present in stimulated PBMC from TB patients and TST+ individuals (Fig. 1A to C). The efficiency of cytolysis was clearly increased after repeated stimulations with the peptides, thus suggesting a continuous enrichment with specific effectors in these cultures. The MHC class I restriction of generated CTL was confirmed with a panel of derivatives of the MHC class I-negative 721.221 cells expressing the HLA-G, HLA-B*2705, or HLA-A*0201 allele. As shown, only cells which expressed the HLA-A*0201 allele and were capable of presenting SodA160-168, AlaDH160-169, and GlnS308-316 peptides were lysed (Fig. 1D to F). Moreover, the peptide-specific cytolysis of targets was inhibited by anti-MHC class I and anti-CD8 MAb but not by MAb to CD4, thus corroborating the MHC class I restriction and CD8 dependency of these effectors (Fig. 1G to I and data not shown).



View larger version (24K):
[in this window]
[in a new window]
  		FIG. 1. HLA-A*0201-restricted and CD8-dependent CTL responses to synthetic and endogenously processed SodA160-168, AlaDH160-169, and GlnS308-316 target peptides. (A to C) Enrichment with specific CTL in PBMC cultures from a TB patient and two TST+ individuals (Table 1) after repeated stimulation with target peptides. CTL activity against T2 cells pulsed with each target or irrelevant TAX11-19 peptides at the indicated effector-to-target (E:T) ratios was measured using lactate dehydrogenase release ELISA. (D to I) The effector S1 line and A1 and G1 clones were tested against respective peptide-pulsed 721.221 transfectants expressing HLA-G (G), HLA-B*2705 (B27), or HLA-A*0201 (A2) alleles and HLA-A*0201-positive T2 cells or against target T2 cells in the presence of MAb to MHC class I (W6) and CD8 (C8). (K to M) Cytolysis of THP-1 cells acutely infected with M. tuberculosis H37Rv (THP + M.tb.) at 4 CFU per cell (40 to 50% infectivity by acid-fast staining) by S1, A1, and G1 effectors at an effector-to-target ratio of 20. Values are the means ± standard deviations of results from triplicate determinations. The composite is representative of results from at least three experiments.

 
To control mycobacterial growth, MHC class I-restricted CD8+ CTL are expected to recognize and respond to their target epitopes presented by M. tuberculosis-infected cells during the natural course of infection. We next examined the ability of CTL specific for SodA160-168, AlaDH160-169, or GlnS308-316 to recognize the endogenously generated epitopes and to exert effector functions against infected targets. Therefore, S1, A1, and G1 effectors were assayed for cytolysis of the HLA-A*0201-positive monocytic cell line THP-1 acutely infected with M. tuberculosis (4). All three peptide-specific effectors were able to recognize and lyse M. tuberculosis-infected THP-1 cells (Fig. 1K to M).

The importance of Th1 cytokines IFN-{gamma} and tumor necrosis factor alpha (TNF-{alpha}) in immune response to M. tuberculosis infection is known (19). Accumulated data indicate that production of these cytokines is an essential effector function of CD8+ T cells responding to the pathogen in humans and mice (10). We therefore investigated whether peptide-specific CTL can release IFN-{gamma} and TNF-{alpha} upon recognition of their targets. First, using enzyme-linked immunosorbent assays (ELISA), we found that peptide-stimulated, CD8-enriched S1, A1, and G1 effectors released IFN-{gamma} and TNF-{alpha} in the range of 0.8 to 1.5 ng/ml and 4.0 to 4.5 ng/ml, respectively (data not shown). Next, the frequencies of cytokine producers among effectors were determined by intracellular staining. Induction of IFN-{gamma} release was significantly more robust in AlaDH-specific CTL, which showed a high frequency (40%) of producers, than in SodA- and GlnS-specific CTL, which showed lower frequencies (6 to 7%) (Fig. 2). TNF-{alpha} producers were detected among all effectors, with frequencies of about 2 to 10%. Differences in frequencies of cytokine producers may reflect the presence of effectors that have similar lytic capabilities but that bear T-cell receptors with differential avidities for the peptide-ligand complexes and/or the presence of functionally distinct CTL not secreting IFN-{gamma} and TNF-{alpha} (13, 27).



View larger version (41K):
[in this window]
[in a new window]
  		FIG. 2. Production of IFN-{gamma} and TNF-{alpha} by SodA-, AlaDH-, and GlnS-specific CTL. S1, A1, and G1 effectors were stimulated with target peptide-pulsed (pep) or nonpulsed (-) T2 cells in the presence of brefeldin A and then tested for the frequency (in percent) of cytokine producers by intracellular staining with MAb to IFN-{gamma} and TNF-{alpha} and flow cytometry analysis. The CTL were 100% CD3+ and CD8+. The histogram profiles were obtained after gating of viable lymphocytes. The total cytokine-producing potential assessed after stimulation with phorbol myristate acetate and ionomycin was 43 to 51%; that is, 43 to 51% of these effectors were IFN-{gamma} and TNF-{alpha} producers (data not shown). The data are representative of results from three experiments. FITC, fluorescein isothiocyanate; PE, phycoerythrin; FL, fluorescence channel; FSC, forward scatter.

 
We have identified three novel immunodominant CTL epitopes, SodA160-168, AlaDH160-169, and GlnS308-316, which are endogenously processed and presented by M. tuberculosis-infected cells. CTL precursors specific for these epitopes and possessing effector functions such as cytolysis and IFN-{gamma} and TNF-{alpha} release can be isolated from peripheral blood of TB patients and/or TST+ individuals. The proteins expressing these CTL epitopes are enzymes with defined roles in the metabolic processes in mycobacteria. In addition, they may be involved in host-pathogen interactions. Thus, SodA detoxifies superoxide anion and is capable of neutralizing oxygen metabolites released from immune cells. This is likely to have a broad effect on infection pathogenesis. Indeed, SodA has been shown to inhibit innate immune responses in a mouse model (6). AlaDH is involved in nitrogen metabolism and has been implicated in the adaptation of mycobacteria to an anaerobic dormant state, a condition that may be related to the state of latent infection (9). Finally, GlnS is similarly involved in another pathway of nitrogen metabolism and is essential for intracellular growth of bacilli in macrophages (25). Therefore, these enzymes appear to be crucial for the survival of mycobacteria and may be the targets of strong cell-mediated host immune responses, as revealed in our studies. Further studies are under way to determine whether the response to these CTL epitopes in TB patients and TST+ individuals is a correlate of immunity to TB.


   ACKNOWLEDGMENTS
 
This work was supported by National Institutes of Health grant HL 59835 (Y.B.) and GCRC grant MO1 00096 (W.N.R.).


   FOOTNOTES
 
* Corresponding author. Mailing address: Laboratory of Molecular Immunology, Public Health Research Institute, 225 Warren Street, Newark, NJ 07103. Phone: (973) 854-3350. Fax: (973) 854-3101. E-mail: yuri{at}phri.org. Back

Editor: S. H. E. Kaufmann


   REFERENCES
Top
 Abstract
 Text
 References
 
1. Andersen, A. B., P. Andersen, and L. Ljungqvist. 1992. Structure and function of a 40,000-molecular-weight protein antigen of Mycobacterium tuberculosis. Infect. Immun. 60:2317-2323.[Abstract/Free Full Text]
2. Andersen, P., D. Askgaard, A. Gottschau, J. Bennedsen, S. Nagai, and I. Heron. 1992. Identification of immunodominant antigens during infection with Mycobacterium tuberculosis. Scand. J. Immunol. 36:823-831.[CrossRef][Medline]
3. Caccamo, N., S. Milano, C. Di Sano, D. Cigna, J. Ivanyi, A. M. Krensky, F. Dieli, and A. Salerno. 2002. Identification of epitopes of Mycobacterium tuberculosis 16-kDa protein recognized by human leukocyte antigen-A*0201 CD8+ T lymphocytes. J. Infect. Dis. 186:991-998.[CrossRef][Medline]
4. Cho, S., V. Mehra, S. Thoma-Uszynski, S. Stenger, N. Serbina, R. J. Mazzaccaro, J. L. Flynn, P. F. Barnes, S. Southwood, E. Celis, B. R. Bloom, R. L. Modlin, and A. Sette. 2000. Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis. Proc. Natl. Acad. Sci. USA 97:12210-12215.[Abstract/Free Full Text]
5. De Groot, A. S., B. M. Jesdale, E. Szu, J. R. Schafer, R. M. Chicz, and G. Deocampo. 1997. An interactive Web site providing major histocompatibility ligand predictions: application to HIV research. AIDS Res. Hum. Retrovir. 13:529-531.[Medline]
6. Edwards, K. M., M. H. Cynamon, R. K. R. Voladri, C. C. Hager, M. S. DeStefano, K. T. Tham, D. L. Lakey, M. R. Bochan, and D. S. Kernodle. 2001. Iron-cofactored superoxide dismutase inhibits host responses to Mycobacterium tuberculosis. Am. J. Respir. Crit. Care Med. 164:2213-2219.[Abstract/Free Full Text]
7. Flynn, J. L., and J. Chan. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19:93-129.[CrossRef][Medline]
8. Geluk, A., K. E. van Meijgaarden, K. L. Franken, J. W. Drijfhout, S. D'Souza, A. Necker, K. Huygen, and T. H. Ottenhoff. 2000. Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans. J. Immunol. 165:6463-6471.[Abstract/Free Full Text]
9. Hutter, B., and T. Dick. 1998. Increased alanine dehydrogenase activity during dormancy in Mycobacterium smegmatis. FEMS Microbiol. Lett. 167:7-11.[CrossRef][Medline]
10. Kerksiek, K. M., and E. G. Pamer. 1999. T cell responses to bacterial infection. Curr. Opin. Immunol. 11:400-405.[CrossRef][Medline]
11. Klein, M. R., S. M. Smith, A. S. Hammond, G. S. Ogg, A. S. King, J. Vekemans, A. Jaye, P. T. Lukey, and K. P. McAdam. 2001. HLA-B*35-restricted CD8 T cell epitopes in the antigen 85 complex of Mycobacterium tuberculosis. J. Infect. Dis. 183:928-934.[CrossRef][Medline]
12. Lalvani, A., R. Brookes, R. J. Wilkinson, A. S. Malin, A. A. Pathan, P. Andersen, H. Dockrell, G. Pasvol, and A. V. Hill. 1998. Human cytolytic and interferon {gamma}-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 95:270-275.[Abstract/Free Full Text]
13. Lawson, T. M., S. Man, E. C. Y. Wang, S. Williams, N. Amos, G. M. Gillespie, P. A. Moss, and L. K. Borysiewicz. 2001. Functional differences between influenza A-specific cytotoxic T lymphocyte clones expressing dominant and subdominant TCR. Int. Immunol. 13:1383-1390.[Abstract/Free Full Text]
14. Margalit, H., J. L. Spouge, J. L. Cornette, K. B. Cease, C. Delisi, and J. A. Berzovsky. 1987. Prediction of immunodominant helper T cell antigenic sites from the primary sequence. J. Immunol. 138:2213-2229.[Abstract]
15. Mohagheghpour, N., D. Gammon, L. M. Kawamura, A. van Vollenhoven, C. J. Benike, and E. G. Engleman. 1998. CTL response to Mycobacterium tuberculosis: identification of an immunogenic epitope in the 19-kDa lipoprotein. J. Immunol. 161:2400-2406.[Abstract/Free Full Text]
16. Nijman, H. W., J. G. Houbiers, M. P. Vierboom, S. H. Van der Burg, J. W. Drijfhout, J. D'Amaro, P. Kenemans, C. J. Melief, and W. M. Kast. 1993. Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes. Eur. J. Immunol. 6:1215-1219.
17. Pathan, A. A., K. A. Wilkinson, R. J. Wilkinson, M. Latif, H. McShane, G. Pasvol, A. V. Hill, and A. Lalvani. 2000. High frequencies of circulating IFN-{gamma}-secreting CD8 cytotoxic T cells specific for a novel MHC class I-restricted Mycobacterium tuberculosis epitope in M. tuberculosis-infected subjects without disease. Eur. J. Immunol. 30:2713-2721.[CrossRef][Medline]
18. Rammensee, H., J. Bachmann, N. P. Emmerich, O. A. Bachor, and S. Stevanovic. 1999. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50:213-219.[CrossRef][Medline]
19. Raupach, B., and S. H. Kaufmann. 2001. Immune responses to intracellular bacteria. Curr. Opin. Immunol. 13:417-428.[CrossRef][Medline]
20. Seder, R. A., and A. V. S. Hill. 2000. Vaccines against intracellular infections requiring cellular immunity. Nature 406:793-798.[CrossRef][Medline]
21. Smith, S. M., R. Brookes, M. R. Klein, A. S. Malin, P. T. Lukey, A. S. King, G. S. Ogg, A. V. Hill, and H. M. Dockrell. 2000. Human CD8+ CTL specific for the mycobacterial major secreted antigen 85A. J. Immunol. 165:7088-7095.[Abstract/Free Full Text]
22. Sonnenberg, M. G., and J. T. Belisle. 1997. Definition of Mycobacterium tuberculosis culture filtrate proteins by two-dimensional polyacrylamide gel electrophoresis, N-terminal amino acid sequencing, and electrospray mass spectrometry. Infect. Immun. 65:4515-4524.[Abstract]
23. Stenger, S., D. A. Hanson, R. Teitelbaum, P. Dewan, K. R. Niazi, C. J. Froelich, T. Ganz, S. Thoma-Uszynski, A. Melian, C. Bogdan, S. A. Porcelli, B. R. Bloom, A. M. Krensky, and R. L. Modlin. 1998. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282:121-125.[Abstract/Free Full Text]
24. Tourdot, S., A. Scardino, W. Sllaloustrou, D. A. Gross, S. Pascolo, P. Cordopatis, F. A. Lemonnier, and K. Kosmatopoulos. 2000. A general strategy to enhance immunogenicity of low-affinity HLA-A2.1-associated peptides: implication in the identification of cryptic tumor epitopes. Eur. J. Immunol. 30:3411-3421.[CrossRef][Medline]
25. Tullius, M. V., G. Harth, and M. A. Horwitz. 2003. Glutamine synthetase GlnA1 is essential for growth of Mycobacterium tuberculosis in human THP-1 macrophages and guinea pigs. Infect. Immun. 71:3927-3936.[Abstract/Free Full Text]
26. Tullius, M. V., G. Harth, and M. A. Horwitz. 2001. High extracellular levels of Mycobacterium tuberculosis glutamine synthetase and superoxide dismutase in actively growing cultures are due to high expression and extracellular stability rather than to a protein-specific export mechanism. Infect. Immun. 69:6348-6363.[Abstract/Free Full Text]
27. Valitutti, S., S. Muller, M. Dessing, and A. Lanzavecchia. 1996. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J. Exp. Med. 183:1917-1921.[Abstract/Free Full Text]

Infection and Immunity, April 2004, p. 2412-2415, Vol. 72, No. 4
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.4.2412-2415.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dong, Y.
Right arrow Articles by Bushkin, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dong, Y.
Right arrow Articles by Bushkin, Y.

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals